Table 1.
Pharmacological agents frequently cited in this review
| CB1 Agonist | CB1 Antagonist | eCB clearance inhibitors |
|||
|---|---|---|---|---|---|
| Δ9-THC | (CB1 = CB2) | SR141716A | (CB1>CB2) | URB597 | FAAH |
| SR147778 | (CB1>CB2) | PF- 3845 |
FAAH | ||
| WIN 55,212-2 | (CB1 ≤ CB2) | AM251 | (CB1>CB2) | ||
| CP 55,940 | (CB1 = CB2) | JZL184 | MAGL | ||
| HU-210 | (CB1 = CB2) | ||||
| AM678 (JWH- 018) |
(CB1 ≥ CB2) | JZL195 | Dual FAAH/MAGL |
||
| R- methanandamide |
(CB1 ≥ CB2) | PMSF | Non-selective serine hydrolase |
||
| ACEA | (CB1 > CB2) | ||||
| O-1812 | (CB1 ≥ CB2) | AM404 | Reuptake/FAAH | ||
| AM1346 | (CB1 ≥ CB2) | OMDM- 2 |
Reuptake | ||